$60,000 of AMNEAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"drug shortages, critical medicines limited to antibiotics and antimicrobials"
You can find more data on corporate lobbying on Quiver Quantitative.
AMRX Insider Trading Activity
AMRX insiders have traded $AMRX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $AMRX stock by insiders over the last 6 months:
- TUSHAR BHIKHUBHAI PATEL sold 5,000,000 shares for an estimated $41,750,000
- GAUTAM PATEL has made 0 purchases and 5 sales selling 320,000 shares for an estimated $2,668,000.
- JASON B. DALY (EVP, Chief Legal Officer) has made 0 purchases and 4 sales selling 147,322 shares for an estimated $1,282,832.
- ANDREW S BOYER (Executive Vice President) sold 125,000 shares for an estimated $1,111,250
- TASOS KONIDARIS (Executive Vice President & CFO) sold 100,000 shares for an estimated $891,000
- EMILY PETERSON ALVA sold 80,000 shares for an estimated $712,000
- DEBORAH M. AUTOR has made 0 purchases and 2 sales selling 40,000 shares for an estimated $334,073.
- JOHN KIELY sold 17,058 shares for an estimated $142,946
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMRX Hedge Fund Activity
We have seen 117 institutional investors add shares of AMRX stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 20,107,524 shares (-92.4%) from their portfolio in Q4 2024, for an estimated $159,251,590
- FOSUN INTERNATIONAL LTD removed 1,720,855 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $13,629,171
- WOODLINE PARTNERS LP removed 1,037,471 shares (-64.7%) from their portfolio in Q4 2024, for an estimated $8,216,770
- NANTAHALA CAPITAL MANAGEMENT, LLC added 995,586 shares (+37.3%) to their portfolio in Q4 2024, for an estimated $7,885,041
- PHOCAS FINANCIAL CORP. removed 813,301 shares (-80.1%) from their portfolio in Q4 2024, for an estimated $6,441,343
- ACADIAN ASSET MANAGEMENT LLC added 546,736 shares (+46.7%) to their portfolio in Q4 2024, for an estimated $4,330,149
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 527,921 shares (-25.5%) from their portfolio in Q4 2024, for an estimated $4,181,134
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMRX Analyst Ratings
Wall Street analysts have issued reports on $AMRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/11/2024
To track analyst ratings and price targets for AMRX, check out Quiver Quantitative's $AMRX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
